Literature DB >> 26193680

Lysozyme-magnesium aluminum silicate microparticles: Molecular interaction, bioactivity and release studies.

Watchara Kanjanakawinkul1, Natalie J Medlicott2, Thomas Rades3, Satit Puttipipatkhachorn4, Thaned Pongjanyakul5.   

Abstract

The objectives of this study were to investigate the adsorption behavior of lysozyme (LSZ) onto magnesium aluminum silicate (MAS) at various pHs and to characterize the LSZ-MAS microparticles obtained from the molecular interaction between LSZ and MAS. The results showed that LSZ could be bound onto the MAS layers at different pHs, leading to the formation of LSZ-MAS microparticles. The higher preparation pH permitted greater adsorption affinity but a lower adsorption capacity of LSZ onto MAS. LSZ could interact with MAS via hydrogen bonds and electrostatic forces, resulting in the formation of intercalated nanocomposites. The particle size, %LSZ adsorbed, and LSZ release rate of LSZ-MAS microparticles increased when the LSZ-MAS ratio was increased. The secondary structure of LSZ bound onto the MAS layers in microparticles prepared at various pHs was altered compared with that of native LSZ. Moreover, the LSZ extracted from microparticles prepared at pH 4 showed an obvious change in the tertiary structure, leading to a decrease in the biological activity of the LSZ released. These findings suggested that LSZ can strongly interact with MAS to form microparticles that may potentially be used as delivery systems for sustained protein release.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bioactivity; Lysozyme; Magnesium aluminum silicate; Microparticles; Protein conformation; Protein release

Mesh:

Substances:

Year:  2015        PMID: 26193680     DOI: 10.1016/j.ijbiomac.2015.07.033

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  1 in total

1.  Intercalated theophylline-smectite hybrid for pH-mediated delivery.

Authors:  Vivek Trivedi; Uttom Nandi; Mohammed Maniruzzaman; Nichola J Coleman
Journal:  Drug Deliv Transl Res       Date:  2018-12       Impact factor: 4.617

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.